Hubei Biocause Pharmaceutical Co., Ltd. approved final cash dividend per 10 A shares (tax included) of CNY 1.10000000 for the year 2022 at its AGM held on 19 May 2023. Record date is 29 May 2023; Ex-date is 30 May 2023; Payment date is 30 May 2023. Net cash dividend/10 shares after tax: CNY 0.99000000 (CNY 1.10000000 - CNY 0.11000000).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 CNY | +0.58% |
|
-1.70% | -39.08% |
Jul. 09 | Biocause Pharmaceutical's Insurance Arm Logs 25 Billion Yuan in Annual Insurance Premium | MT |
Jun. 17 | Biocause Pharma Plans Buyback of Up to 100 Million Yuan Shares | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.08% | 1.18B | |
+9.36% | 77.41B | |
+12.35% | 52.64B | |
+10.95% | 52.19B | |
+26.37% | 48.49B | |
+18.86% | 44.26B | |
+23.27% | 39.65B | |
+16.44% | 33.1B | |
+43.61% | 29.62B | |
-8.64% | 27.43B |
- Stock Market
- Equities
- 000627 Stock
- News Hubei Biocause Pharmaceutical Co., Ltd.
- Hubei Biocause Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 30 May 2023